Cogent Biosciences(COGT)

12.50 -0.41 -3.1758%

今开:12.95昨收:12.91
最高:12.95 最低:12.45
涨停价:0.0跌停价:0.0
总市值:8.73667925E8

Cogent Biosciences的热门评论

chuminhua06-11 11:42

6月10日,Cogent Biosciences 的股价上涨了 78%,此前该公司报告了强效、选择性 KIT D816V 抑制剂bezuclastinib用于晚期系统性肥大细胞增多症患者中治疗的 II 期试验的“积极”初步数据。
截至 5 月 24 日的数据截止日期,该开放标签试验已经在四个剂量水平中的1个治疗了 11 名患者。两名患者...查看全文

季度财报

Cogent Biosciences(COGT)11-14 20:33

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)11-14 20:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:37

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:42

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)09-07 04:36

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)08-09 19:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-015744 Act: 34 Size: 489 KB 网页链接查看全文

季度财报

Cogent Biosciences(COGT)08-09 19:42

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-015760 Act: 34 Size: 6 MB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)07-09 05:06

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010347 Act: 34 Size: 12 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)07-06 01:57

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024929 Size: 5 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Cogent Biosciences的最新评论

Cogent Biosciences(COGT)2021-01-07 10:51

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-000793 Size: 9 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-12-10 10:18

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-033232 Size: 9 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-12-08 03:46

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032853 Size: 9 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-12-03 22:36

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-20-022880 Act: 34 Size: 192 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-12-03 06:21

$Cogent Biosciences(COGT)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-20-308495 Act: 33 Size: 923 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-12-03 06:12

$Cogent Biosciences(COGT)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001193125-20-308501 Act: 34 Size: 234 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-12-02 19:06

$Cogent Biosciences(COGT)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-20-307560 Act: 33 Size: 51 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-12-01 06:30

$Cogent Biosciences(COGT)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-20-305790 Act: 33 Size: 926 KB 网页链接查看全文

Cogent Biosciences(COGT)2020-12-01 06:12

$Cogent Biosciences(COGT)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-20-305716 Act: 34 Size: 7 MB 网页链接查看全文

Cogent Biosciences(COGT)2020-11-20 05:18

$Cogent Biosciences(COGT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-20-000653 Act: 34 Size: 86 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Cogent Biosciences的新闻

Cogent Biosciences(COGT)宣布发行1.25亿美元的普通股

Cogent Biosciences(COGT)宣布已开始承销公开发行1.25亿美元的普通股。Cogent打算将此次发行的净收益用于与bezuclastinib和其他候选产品相关的开发、监管和商业准备活动,以及营运资金和一般公司用途。Jefferies、Piper Sandler& Co.和Gugge... 网页链接

Cogent Biosciences的公告

季度财报

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接

当期报告

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接

季度财报

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-015760 Act: 34 Size: 6 MB 网页链接

当期报告

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-015744 Act: 34 Size: 489 KB 网页链接

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010347 Act: 34 Size: 12 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024929 Size: 5 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024930 Size: 5 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20